OpenAI and Retro Biosciences Team Up to Extend Human Lifespan with AI

OpenAI & Retro Biosciences team up to extend human lifespan using AI.
Matilda
OpenAI and Retro Biosciences Team Up to Extend Human Lifespan with AI
Leveraging GPT-4b micro, the collaboration aims to re-engineer proteins for generating youthful stem cells In a groundbreaking new initiative, OpenAI, the renowned artificial intelligence research laboratory, is joining forces with Retro Biosciences, a rising star in the longevity science field, to push the boundaries of human life expectancy. Their collaborative effort centers around utilizing the capabilities of a novel AI model, GPT-4b micro, to engineer proteins that hold the potential to reverse aging and revitalize human cells. Retro Biosciences: Pioneering Longevity Research Retro Biosciences, a company co-founded by Sam Altman, a prominent figure in the tech industry, is dedicated to achieving a remarkable feat – extending the human lifespan by a decade. Through dedicated research endeavors, they aim to unlock the secrets of cellular rejuvenation and develop therapies that can combat the inevitable process of aging. The Power of GPT-4b micro: Re-engineering Yamanaka Factors OpenAI&…